skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 234  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study
Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study
Material Type:
Article 		Add to My Research

Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study

PloS one, 2020-01, Vol.15 (1), p.e0227557-e0227557 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Hamilton et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Hamilton et al 2020 Hamilton et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0227557 ;PMID: 31961888

Full text available

Citations Cited by
2
Long-term outcomes of aflibercept treatment for neovascular age-related macular degeneration in a clinical setting
Long-term outcomes of aflibercept treatment for neovascular age-related macular degeneration in a clinical setting
Material Type:
Article 		Add to My Research

Long-term outcomes of aflibercept treatment for neovascular age-related macular degeneration in a clinical setting

American journal of ophthalmology, 2017-02, Vol.174, p.160-168 [Peer Reviewed Journal]

Elsevier Inc. ;2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Feb 01, 2017 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2016.09.038 ;PMID: 27746298 ;CODEN: AJOPAA

Full text available

Citations Cited by
3
Depression and alcohol use disorder at antiretroviral therapy initiation led to disengagement from care in South Africa
Depression and alcohol use disorder at antiretroviral therapy initiation led to disengagement from care in South Africa
Material Type:
Article 		Add to My Research

Depression and alcohol use disorder at antiretroviral therapy initiation led to disengagement from care in South Africa

PloS one, 2017-12, Vol.12 (12), p.e0189820 [Peer Reviewed Journal]

COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Cichowitz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Cichowitz et al 2017 Cichowitz et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0189820 ;PMID: 29281681

Full text available

Citations Cited by
4
Widefield optical coherence tomography angiography for early detection and objective evaluation of proliferative diabetic retinopathy
Widefield optical coherence tomography angiography for early detection and objective evaluation of proliferative diabetic retinopathy
Material Type:
Article 		Add to My Research

Widefield optical coherence tomography angiography for early detection and objective evaluation of proliferative diabetic retinopathy

British journal of ophthalmology, 2021-01, Vol.105 (1), p.118-123 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2019-315365 ;PMID: 32193221

Full text available

Citations Cited by
5
Direct Observations of the Metal−Ligand Bifunctional Addition Step in an Enantioselective Ketone Hydrogenation
Direct Observations of the Metal−Ligand Bifunctional Addition Step in an Enantioselective Ketone Hydrogenation
Material Type:
Article 		Add to My Research

Direct Observations of the Metal−Ligand Bifunctional Addition Step in an Enantioselective Ketone Hydrogenation

Journal of the American Chemical Society, 2008-09, Vol.130 (36), p.11979-11987 [Peer Reviewed Journal]

Copyright © 2008 American Chemical Society ;ISSN: 0002-7863 ;EISSN: 1520-5126 ;DOI: 10.1021/ja8034812 ;PMID: 18702465

Full text available

Citations Cited by
6
Real-world outcomes of ranibizumab treatment for diabetic macular edema in a United Kingdom National Health Service setting
Real-world outcomes of ranibizumab treatment for diabetic macular edema in a United Kingdom National Health Service setting
Material Type:
Article 		Add to My Research

Real-world outcomes of ranibizumab treatment for diabetic macular edema in a United Kingdom National Health Service setting

American journal of ophthalmology, 2016-12, Vol.172, p.51-57 [Peer Reviewed Journal]

Elsevier Inc. ;2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 01, 2016 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2016.09.002 ;PMID: 27637784 ;CODEN: AJOPAA

Full text available

Citations Cited by
7
Intravitreal injections: past trends and future projections within a UK tertiary hospital
Intravitreal injections: past trends and future projections within a UK tertiary hospital
Material Type:
Article 		Add to My Research

Intravitreal injections: past trends and future projections within a UK tertiary hospital

Eye (London), 2022-07, Vol.36 (7), p.1373-1378 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 0950-222X ;EISSN: 1476-5454 ;DOI: 10.1038/s41433-021-01646-3 ;PMID: 34172943

Full text available

Citations Cited by
8
Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study
Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study
Material Type:
Article 		Add to My Research

Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study

PloS one, 2020-12, Vol.15 (12), p.e0244183 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Holz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Holz et al 2020 Holz et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0244183 ;PMID: 33378369

Full text available

Citations Cited by
9
FENETRE study: quality-assured follow-up of quiescent neovascular age-related macular degeneration by non-medical practitioners: study protocol and statistical analysis plan for a randomised controlled trial
FENETRE study: quality-assured follow-up of quiescent neovascular age-related macular degeneration by non-medical practitioners: study protocol and statistical analysis plan for a randomised controlled trial
Material Type:
Article 		Add to My Research

FENETRE study: quality-assured follow-up of quiescent neovascular age-related macular degeneration by non-medical practitioners: study protocol and statistical analysis plan for a randomised controlled trial

BMJ open, 2021-05, Vol.11 (5), p.e049411-e049411 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2021-049411 ;PMID: 33980536

Full text available

Citations Cited by
10
UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice
UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice
Material Type:
Article 		Add to My Research

UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice

British journal of ophthalmology, 2017-12, Vol.101 (12), p.1683-1688 [Peer Reviewed Journal]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;Copyright: 2017 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2016-309818 ;PMID: 28478396

Full text available

Citations Cited by
11
Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance
Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance
Material Type:
Article 		Add to My Research

Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance

PloS one, 2018-05, Vol.13 (5), p.e0197072-e0197072 [Peer Reviewed Journal]

COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 Muqit et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Muqit et al 2018 Muqit et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0197072 ;PMID: 29768451

Full text available

Citations Cited by
12
Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
Material Type:
Article 		Add to My Research

Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting

Ophthalmology and therapy, 2018-12, Vol.7 (2), p.361-368 [Peer Reviewed Journal]

The Author(s) 2018 ;Ophthalmology and Therapy is a copyright of Springer, (2018). All Rights Reserved. ;ISSN: 2193-8245 ;EISSN: 2193-6528 ;DOI: 10.1007/s40123-018-0139-5 ;PMID: 29982914

Full text available

Citations Cited by
13
Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT
Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT
Material Type:
Article 		Add to My Research

Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT

Health technology assessment (Winchester, England), 2022-12, Vol.26 (50), p.1-86 [Peer Reviewed Journal]

ISSN: 1366-5278 ;EISSN: 2046-4924 ;DOI: 10.3310/SZKI2484 ;PMID: 36541393

Full text available

Citations Cited by
14
A study of patient attitudes towards decentralisation of HIV care in an urban clinic in South Africa
A study of patient attitudes towards decentralisation of HIV care in an urban clinic in South Africa
Material Type:
Article 		Add to My Research

A study of patient attitudes towards decentralisation of HIV care in an urban clinic in South Africa

BMC health services research, 2011-08, Vol.11 (1), p.205-205, Article 205 [Peer Reviewed Journal]

COPYRIGHT 2011 BioMed Central Ltd. ;Copyright ©2011 Mukora et al; licensee BioMed Central Ltd. 2011 Mukora et al; licensee BioMed Central Ltd. ;ISSN: 1472-6963 ;EISSN: 1472-6963 ;DOI: 10.1186/1472-6963-11-205 ;PMID: 21871068

Full text available

Citations Cited by
15
Eccentric Viewing Training for Age-Related Macular Disease: Results of a Randomized Controlled Trial (the EFFECT Study)
Eccentric Viewing Training for Age-Related Macular Disease: Results of a Randomized Controlled Trial (the EFFECT Study)
Material Type:
Article 		Add to My Research

Eccentric Viewing Training for Age-Related Macular Disease: Results of a Randomized Controlled Trial (the EFFECT Study)

Ophthalmology science (Online), 2024-03, Vol.4 (2), p.100422-100422 [Peer Reviewed Journal]

2023 by the American Academy of Ophthalmology. ;EISSN: 2666-9145 ;DOI: 10.1016/j.xops.2023.100422 ;PMID: 38187128

Full text available

Citations Cited by
16
Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial
Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial
Material Type:
Article 		Add to My Research

Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial

Current controlled trials in cardiovascular medicine, 2019-02, Vol.20 (1), p.122-122, Article 122 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1745-6215 ;EISSN: 1745-6215 ;EISSN: 1468-6694 ;DOI: 10.1186/s13063-019-3199-5 ;PMID: 30755274

Full text available

Citations Cited by
17
"That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme
"That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme
Material Type:
Article 		Add to My Research

"That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme

BMC public health, 2008-02, Vol.8 (1), p.63-63, Article 63 [Peer Reviewed Journal]

COPYRIGHT 2008 BioMed Central Ltd. ;Copyright © 2008 Dahab et al; licensee BioMed Central Ltd. 2008 Dahab et al; licensee BioMed Central Ltd. ;ISSN: 1471-2458 ;EISSN: 1471-2458 ;DOI: 10.1186/1471-2458-8-63 ;PMID: 18282286

Full text available

Citations Cited by
18
Visual and Anatomical Outcomes of a Single Intravitreal Dexamethasone in Diabetic Macular Edema: An 8 Year Real-World Study
Visual and Anatomical Outcomes of a Single Intravitreal Dexamethasone in Diabetic Macular Edema: An 8 Year Real-World Study
Material Type:
Article 		Add to My Research

Visual and Anatomical Outcomes of a Single Intravitreal Dexamethasone in Diabetic Macular Edema: An 8 Year Real-World Study

Journal of clinical medicine, 2023-06, Vol.12 (12), p.3878 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2077-0383 ;EISSN: 2077-0383 ;DOI: 10.3390/jcm12123878 ;PMID: 37373573

Full text available

Citations Cited by
19
Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model
Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model
Material Type:
Article 		Add to My Research

Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model

BMJ open, 2022-04, Vol.12 (4), p.e057269-e057269 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2022 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2021-057269 ;PMID: 35428639

Full text available

Citations Cited by
20
A Ruthenium−Dihydrogen Putative Intermediate in Ketone Hydrogenation
A Ruthenium−Dihydrogen Putative Intermediate in Ketone Hydrogenation
Material Type:
Article 		Add to My Research

A Ruthenium−Dihydrogen Putative Intermediate in Ketone Hydrogenation

Journal of the American Chemical Society, 2005-03, Vol.127 (12), p.4152-4153 [Peer Reviewed Journal]

Copyright © 2005 American Chemical Society ;2005 INIST-CNRS ;ISSN: 0002-7863 ;EISSN: 1520-5126 ;DOI: 10.1021/ja043339k ;PMID: 15783180 ;CODEN: JACSAT

Full text available

Citations Cited by

Results 1 - 20 of 234  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (82)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1983  (24)
  2. 1983 To 1996  (31)
  3. 1997 To 2005  (89)
  4. 2006 To 2015  (35)
  5. After 2015  (55)
  6. More options open sub menu

Language 

  1. English  (215)
  2. French  (45)
  3. German  (33)
  4. Japanese  (7)
  5. Spanish  (3)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait